al102
ayala pharmaceuticalsceuticals,novartis
['al102', 'ayala']
we are excited to share interim data on al102 from part a of the phase 2/3 ringside study targeting desmoid tumors at the european society for medical oncology congress #esmo2022. for more information: 
Clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for rare and aggressive cancers.